Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit?
Abstract Objective The aim of the present study is to list the published clinical trials on coronavirus disease 2019 (COVID-19) vaccines, to describe the mechanism of action of the identified vaccines, and to identify protocols regarding safety, status, and prioritization of cancer patients for vac...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
2022-08-01
|
Series: | Revista Brasileira de Ginecologia e Obstetrícia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032022000600602&tlng=en |
_version_ | 1811321379991060480 |
---|---|
author | Bruno Eduardo Pereira Laporte Estela Gelain Junges Laporte Paula Fonseca Aarestrup Matheus Fonseca Aarestrup Fernando Monteiro Aarestrup |
author_facet | Bruno Eduardo Pereira Laporte Estela Gelain Junges Laporte Paula Fonseca Aarestrup Matheus Fonseca Aarestrup Fernando Monteiro Aarestrup |
author_sort | Bruno Eduardo Pereira Laporte |
collection | DOAJ |
description | Abstract Objective The aim of the present study is to list the published clinical trials on coronavirus disease 2019 (COVID-19) vaccines, to describe the mechanism of action of the identified vaccines, and to identify protocols regarding safety, status, and prioritization of cancer patients for vaccination. Methods This is a systematic review with a limited literature search conducted by an information specialist; key resources such as PubMed and websites of major cancer organizations were searched. The main search terms were COVID-19, vaccination, cancer, and breast and gynecological cancers. Results Cancer patients infected with the new coronavirus are at high risk of complications and death, but we still know little about the risks and benefits of vaccination for COVID-19 in these patients. In an ideal scenario, all cancer patients should have their immunization status updated before beginning treatment, but this is not always possible. Conclusion Patients with breast or gynecological cancers who are receiving treatment or are in the 5-year posttreatment period should be included in the priority group for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination. |
first_indexed | 2024-04-13T13:16:45Z |
format | Article |
id | doaj.art-de5aba60813946f5996386a17ba0bf12 |
institution | Directory Open Access Journal |
issn | 0100-7203 |
language | English |
last_indexed | 2024-04-13T13:16:45Z |
publishDate | 2022-08-01 |
publisher | Federação Brasileira das Sociedades de Ginecologia e Obstetrícia |
record_format | Article |
series | Revista Brasileira de Ginecologia e Obstetrícia |
spelling | doaj.art-de5aba60813946f5996386a17ba0bf122022-12-22T02:45:28ZengFederação Brasileira das Sociedades de Ginecologia e ObstetríciaRevista Brasileira de Ginecologia e Obstetrícia0100-72032022-08-0144660260810.1055/s-0042-1745788Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit?Bruno Eduardo Pereira Laportehttps://orcid.org/0000-0003-3691-2653Estela Gelain Junges Laportehttps://orcid.org/0000-0001-5577-3121Paula Fonseca Aarestruphttps://orcid.org/0000-0001-6623-8941Matheus Fonseca Aarestruphttps://orcid.org/0000-0001-6750-747XFernando Monteiro Aarestruphttps://orcid.org/0000-0001-9226-8271Abstract Objective The aim of the present study is to list the published clinical trials on coronavirus disease 2019 (COVID-19) vaccines, to describe the mechanism of action of the identified vaccines, and to identify protocols regarding safety, status, and prioritization of cancer patients for vaccination. Methods This is a systematic review with a limited literature search conducted by an information specialist; key resources such as PubMed and websites of major cancer organizations were searched. The main search terms were COVID-19, vaccination, cancer, and breast and gynecological cancers. Results Cancer patients infected with the new coronavirus are at high risk of complications and death, but we still know little about the risks and benefits of vaccination for COVID-19 in these patients. In an ideal scenario, all cancer patients should have their immunization status updated before beginning treatment, but this is not always possible. Conclusion Patients with breast or gynecological cancers who are receiving treatment or are in the 5-year posttreatment period should be included in the priority group for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032022000600602&tlng=encancerCOVID-19vaccinationprotocols |
spellingShingle | Bruno Eduardo Pereira Laporte Estela Gelain Junges Laporte Paula Fonseca Aarestrup Matheus Fonseca Aarestrup Fernando Monteiro Aarestrup Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit? Revista Brasileira de Ginecologia e Obstetrícia cancer COVID-19 vaccination protocols |
title | Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit? |
title_full | Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit? |
title_fullStr | Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit? |
title_full_unstemmed | Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit? |
title_short | Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit? |
title_sort | coronavirus disease 2019 vaccination for cancer patients risk or benefit |
topic | cancer COVID-19 vaccination protocols |
url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032022000600602&tlng=en |
work_keys_str_mv | AT brunoeduardopereiralaporte coronavirusdisease2019vaccinationforcancerpatientsriskorbenefit AT estelagelainjungeslaporte coronavirusdisease2019vaccinationforcancerpatientsriskorbenefit AT paulafonsecaaarestrup coronavirusdisease2019vaccinationforcancerpatientsriskorbenefit AT matheusfonsecaaarestrup coronavirusdisease2019vaccinationforcancerpatientsriskorbenefit AT fernandomonteiroaarestrup coronavirusdisease2019vaccinationforcancerpatientsriskorbenefit |